Tianjin Institute of Metrological Supervision and Testing, 300192, Tianjin, PR China.
Photochem Photobiol Sci. 2018 Oct 10;17(10):1337-1345. doi: 10.1039/c8pp00198g.
Photothermal therapy (PTT) is providing new opportunities for killing cancer cells. In this work, we introduce a new nanomedicine based on spherical MoS2 nanoparticles for PTT treatment of tumors, prepared using "green" bottom-up technology. To increase water solubility and avoid rapid clearance by the reticuloendothelial system, polyethylene glycol (PEG) was used to coat them. These MoS2-PEG nanospheres with an appropriate size (∼100 nm) exhibit high photothermal conversion efficiency (26.7%). In vitro cellular studies revealed that the MoS2-PEG nanospheres showed negligible cytotoxicity. Additionally, through combining the MoS2-PEG nanosphere samples with NIR irradiation at 808 nm, excellent in vitro tumor cell killing efficacy was achieved. In the 4T1 tumor model, the MoS2-PEG nanospheres exhibited good antitumor efficiency in vivo, displaying complete tumor inhibition over 16 days after treatment. Therefore, MoS2-PEG nanospheres played an important role in tumor destruction, and this concept for developing spherical MoS2-based nanomedicines can serve as a platform technology for the next generation of in vivo PTT agents.
光热疗法(PTT)为杀死癌细胞提供了新的机会。在这项工作中,我们介绍了一种基于球状 MoS2 纳米粒子的新型纳米医学,用于肿瘤的 PTT 治疗,该纳米医学是使用“绿色”自下而上的技术制备的。为了提高水溶性并避免网状内皮系统的快速清除,使用了聚乙二醇(PEG)对其进行了涂层处理。这些具有适当尺寸(约 100nm)的 MoS2-PEG 纳米球具有很高的光热转换效率(26.7%)。体外细胞研究表明,MoS2-PEG 纳米球的细胞毒性可忽略不计。此外,通过将 MoS2-PEG 纳米球样品与 808nm 的近红外辐射相结合,实现了优异的体外肿瘤细胞杀伤效果。在 4T1 肿瘤模型中,MoS2-PEG 纳米球在体内表现出良好的抗肿瘤效率,在治疗后 16 天内完全抑制了肿瘤。因此,MoS2-PEG 纳米球在肿瘤破坏中发挥了重要作用,这种开发基于球状 MoS2 的纳米医学的概念可以作为下一代体内 PTT 制剂的平台技术。